GOODNAK: New Skin Renewal Treatments
AMDL launches new products for its GOODNAK skin anti-aging line.
The company is releasing the new GOODNAK formulations in partnership with JJB, the subsidiary of AMDL's Chinese subsidiary Jade Pharmaceutical Inc. (JPI). Scheduled to be released next month, the GOODNAK product includes Human Placental Histosolution, and effective and key component in anti-aging products which has been shown to give skin a youthful look by increasing cell renewal and smoothening fine lines.
JJB has applied to Chinese regulatory authorities for product approval and anticipates sanction this month. Based on the general market information, the proposed pricing for the new GOODNAK products is anticipated to be approximately (U.S.)$40.00 per unit with a 60% gross profit margin.
Frank Zhang, managing Director of JPI, stated that, "the new GOODNAK consumer products are expected to be highly popular and anticipated sales growth is expected to significantly increase in 2008 and beyond. This product may also be extremely an exceptionally good candidate for export to the North American and European beauty care markets."